معرفی
Pierluigi Bove is an Associate Professor in Urology at the University of Rome Tor Vergata, specializing in minimally-invasive surgical oncology. He leads research on urologic cancers and novel surgical technologies, with over 4,500 major surgical procedures performed. His clinical expertise includes robotic surgery, laparoscopic techniques, and urologic oncology.
His research program focuses on minimally-invasive surgical oncology for prostate, kidney, and bladder cancers. Current investigations include randomized clinical trials comparing surgical techniques and analyses of genetic/epigenetic biomarkers for urological cancers. Key research areas include surgical outcomes optimization, treatment efficacy studies, and diagnostic protocol development.
Publications demonstrate a strong focus on urologic oncology innovations, with recent articles exploring surgical techniques, diagnostic imaging advances, and treatment efficacy studies. Trends show increasing specialization in robotic surgical applications and biomarker research for personalized urologic care.
He maintains academic collaborations through multiple research groups including Torvergata Oncoscience Research (TOR) and serves on surgical advisory boards for medical device companies.
